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Abstract
BACKGROUND: The peripheral arterial embolism (PAE) is a sudden decrease in limb perfusion due to acute 
occlusion of peripheral artery which leads to ischemic tissue damage, that can threaten the limb of a patient and 
requires immediate revascularization. It is estimated that the incidence of acute limb emoblism in the general 
population is around 14/100,000 inhabitants per year. Accurate and timely diagnosis is crucial to salvage the patient’s 
limb and sometimes the patient’s life.  In cases of complete arterial occlusion and absence of collateral perfusion, 
irreversible damage can occur within 4 to 6 hours. The fundamental definition for treatment of acute peripheral 
arterial embolism is revascularisation. Revascularisation is either performed endovascularly or by an open surgical 
approach. A suspicion of acute ischemia based on history and physical examination warrants heparin administration 
and vascular surgery consultation. Delays in the management of acute peripheral arterial ischemia due to an 
embolism are common and associated with poor limb - salvage outcomes.
AIM: Our study aims to identify medical consultations and cardiovascular assessments undergone by patients in the 
period prior to being hospitalised, in order to evaluate for missed or delayed opportunities for diagnosis.
METHODS: Retrospective cohort study, utilising the medical documentation and previous outpatiently or inhospital 
consultations. Adult patients undergone treatment due to peripheral arterial embolism were identified and analyzed. 
Patients were identified through the administrative hospital database using the International Classification of 
Diseases.  Hospitalised patients with those medcodes between 1st January 2010 - 1st March 2020 were recorded.
RESULTS: Following exclusion, 424 patients (mean age 68.5 ± 5.85 years) were included. 159 patients (66.8%) 
had visited their family doctors or other medical specialist before admission and in all of the cases was initiated 
therapeutic approach. The rest of the cohort 79 patients (33.2%) presented lately due to other social reasons. The 
group of 159 patients that admitted lately due to medical indications - diagnostic, healthcare - administrative or 
treatment related problems are subject of our study. The largest group including 113 (71%) patients were treated 
outpatientley by vascular surgeons with preventative medications.17 patients (10.6%) were directed outpatientley 
to orthopaedic surgeon due to suspicion of trauma.15 patients (9.4%) were treated by their family doctors with 
pain relief medications. The rest of the 14 patients (8.8%) were treated by neurosurgeons or neurologists due to a 
suspicion of cauda eniqua and other neuropathies. The majority of the patients 108 (67.9%) were free of complains 
at the discharge, 11.3% of the studied cohort were with minimal post-treatment complains (numbness, coldness, 
absent peripheral pulsations, insignificant claudicatio). Amputation rate was 14.4%, incidence of rethrombosis 8.8% 
and recurrent embolism frequency around 3.7%. Death was registered in 21 cases (13.2%).
CONCLUSION: The consequences of acute limb embolism such as prolonged hospitalization, major limb 
amputation, and/or death have a profound socioeconomic impact. Unrecognition of this vascular pathology and 
differential diagnosis difficulties are possibly leading factors for delayed or missed treatment.
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Introduction
The peripheral arterial embolism (PAE) is 
a sudden decrease in limb perfusion due to acute 
occlusion of peripheral artery which leads to ischemic 
tissue damage that can threaten the limb of a patient 
and requires immediate revascularization. It is estimated 
that the incidence of acute limb embolism in the general 
population is around 14/100,000 inhabitants per year [1].
Accurate and timely diagnosis is crucial to 
salvage the patient’s limb and sometimes the patient’s life. 
In cases of complete arterial occlusion and 
absence of collateral perfusion, irreversible damage 
can occur within 4–6 h [2], [3], [4].
The fundamental definition for the treatment 
of acute PAE is revascularization. Revascularization is 
either performed endovascularly, where a thrombolytic 
agent is delivered directly into the thrombus through 
a catheter positioned from a Seldinger groin 
puncture [2], [5], [6], or by an open surgical approach, 
most commonly as a thromboembolectomy [8].
Despite recent technical advancements in 
revascularization treatment options, amputation and 
mortality rates remain high in patients with PAE [7], [8]. The 
time passed from the onset of symptoms to revascularization 
has been linked to patient outcome [8], [9].
A suspicion of acute ischemia based on 
history and physical examination warrants heparin 
administration and vascular surgery consultation [10].
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Delays in the management of acute peripheral 
arterial ischemia due to an embolism are common and 
associated with poor limb salvage outcomes.
In aging population, primary major amputations 
(AMP, below-knee or above-knee) continue to be 
performed despite advances in revascularization. 
A hypothesis that not only patient comorbidities but 
also the system of health-care delivery affected the 
treatment of patients with acute arterial limb ischemia 
could be eligible [11].
At present, there are suspicions whether 
opportunities for timely recognition in general practice 
and other more specialized medical practice exist and 
are potentially being delayed or missed. Our study aims 
to identify medical consultations and cardiovascular 
assessments undergone by patients in the period 
before being hospitalized, to evaluate for missed or 
delayed opportunities for diagnosis.
Methods
Retrospective cohort study utilize the medical 
documentation and previous outpatient or in hospital 
consultations. Adult patients undergone treatment due 
to PAE were identified and analyzed.
Patients were identified through the 
administrative hospital database using the International 
Classification of Diseases, 10th revision (ICD-10) 
codes “Embolism and thrombosis of arteries of upper 
extremities,” – I74.2, I74.3 – “Embolism and thrombosis 
of arteries of the lower extremities,” I74.5 – “Embolism 
and thrombosis of iliac artery,” and I74.0 – “Embolism 
and thrombosis of abdominal aorta.”
Hospitalized patients with those medcodes 
between January 1, 2010, and March 1, 2020, were 
recorded.
Gama CodeMasters – an administrative 
hospital database was used to exclude patients treated 
due to acute post-traumatic arterial ischemia or acute 
ischemia due to peripheral arterial disease (PAD).
The total number of outpatient examinations, 
hospital treatment, and their latest consultation before 
admission was identified.
Results
Following exclusion, 424 patients (mean age 
68.5 ± 5.85 years) were included. About 45.9% of the 
cohort were recorded as having arterial hypertension as 
most common comorbidity followed by atrial fibrillation 
in 33.5% of the cases. About 56% (238 patients) 
presented in our clinic more than 12 h after onset of the 
symptoms, 159 patients (66.8%) had visited their family 
doctors or other medical specialist before admission and 
in all of the cases was initiated therapeutic approach. 
The rest of the cohort 79 patients (33.2%) presented 
lately due to other social reasons.
The group of 159 patients that admitted lately 
due to medical indications – diagnostic, health care – 
administrative or treatment-related problems is subject 
of our study. The largest group including 113 (71%) 
patients was treated outpatient by vascular surgeons 
with preventative medications as followed: Antiplatelet 
(79.6%), vasoactive (76.1%), analgetics (62.8%), 
and lipid lowering agents (31.8%) with poor outcome. 
This group represented major interest for our study to 
analyze and investigate the reasons for late referring 
to vascular surgery department and, respectively, 
delays in treatment. Physical state and clinical stage 
of the extremity in all of 113 cases treated outpatient 
by vascular surgeons are presented in Table 1 
based on clinical stage according to the Rutherford 
recommended standards for reporting lower extremity 
ischemia.
Table 1: Distribution of the stages
Stages 113 patients
I stage (Viable ischemia) 18 (15.9%)
II-a stage (Threatened marginal) 27 (23.9%)
II-b stage (Threatened: Immediate) 35 (31%)
III stage (Irreversible ) 33 (29.2%)
The largest number of patients referred lately 
to our clinic was with threatened marginal ischemia, 24 
of them 68.5% had PAD as a primary comorbidity. In 
all of the cases, treatment approach was initiated with 
vasoactive medications due to suspicion of CLI.
Age, comorbidities, risk factors, and medication 
use of the 113 patients treated outpatient by vascular 
surgeons are presented in Table 2.
Table 2: Age, comorbitidies, risk factors and medication use
Variables 113 patients
Age >70 years 76 (67.2%)
Hypertension 68 (60.1%)
Diabetes 43 (38.05%)
Smokers 42 (37.1%)
Peripheral arterial disease 64 (56.6%)
Cardiac pathology (AF, CAD, CHF, and incl. past myocardial infarction) 52 (46.01%)
Cerebrovascular disease 39 (34.5%)
Medication use (before admission) 90 (79.6%)
Seventeen patients (10.6%) were directed 
outpatient to orthopedic surgeon due to suspicion of 
trauma, after reviewing medical documentations and 
clinical data provided by patients in all of the cases 
history of trauma were absent.
Fifteen patients (9.4%) were treated by their 
family doctors with pain relief medications.
The rest of the 14 patients (8.8%) were 
treated by neurosurgeons or neurologists due to a 
suspicion of cauda equina and other neuropathies, all 
14 patients of these group were treated in hospital. 
In these group was registered worse mortality rate 
28.5% (4 of 14), all 4 death cases were with aortic 
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saddle embolism untreated at least 15 h from onset 
of the symptoms. 
Treatment approach in all 159 patients is 
presented in Table 3. About 61% of the patients despite 
the delay underwent embolectomy alone.
Table 3: Treatment approach
Treatment approach n = 159
Embolectomy alone 97 (61%)
Embolectomy + other arterial reconstruction (bypass, TEA, etc.) 21 (13.2%)
Embolectomy + minor amputation 9 (5.7%)
Primary major amputation 16 (10%)
MAT 1 (0.6%)
Thrombolysis 1 (0.6%)
Conservative treatment 14 (8.9%)
In 21 cases, embolectomy was insufficient and was 
amplified by other arterial reconstruction (aorta-femoral 
bypass in 1 patient, indirect iliac endarterectomy in 6 
cases, Common femoral artery (CFA), and profunda 
femoral artery (PFA) endarterectomy in 9 cases, and 
in 5 occasions was performed femoropopliteal bypass 
above the knee). Sixteen patients due to the irreversible 
ischemia underwent primary major amputation, in 5.7% 
despite successfully performed embolectomy, the 
necessity of minor amputation was present. One patient 
was treated with mechanical aspiration thrombectomy 
and also one patient underwent thrombolysis.
Fourteen patients due to a viable compensated 
ischemia and because of very high operative risk were 
treated conservatively.
Post-treatment outcome and overall mortality 
are presented in Table 4.
Table 4: Post-treatment outcome and overall mortality
Outcome n = 159
Free of complains 108 (67.9%)
Minimal complains (numbness, coldness, absent peripheral pulsations, 
claudication)
18 (11.3%)
Amputation 23 (14.4%)
Rethrombosis 14 (8.8%)
Recurrent embolism 6 (3.7%)
Fasciotomy 19 (11.9%)
Operative site infection 7 (4.4%)
Death (in hospital or 30 deaths post-submission) 21 (13.2%)
The majority of the patients 108 (67.9%) 
were free of complains at the discharge, 11.3% of 
the studied cohort were with minimal post-treatment 
complains (numbness, coldness, absent peripheral 
pulsations, and insignificant claudication). Amputation 
rate was 14.4%, incidence of rethrombosis 8.8%, and 
recurrent embolism frequency around 3.7%. Death was 
registered in 21 cases (13.2%).
Discussion
Acute PAE is a vascular pathology that can 
be diagnosed and treated in a short time. Mortality 
and morbidity are significantly reduced after timely and 
accurate diagnosis and treatment.
Delayed diagnosis in certain cases may be 
caused by clinical course of the embolism hidden under 
the guise of a post-operative condition or a severe 
comorbid state [12].
Pre-transfer management decisions by 
referring hospitals to an academic tertiary care facility 
for ALI patients occur less frequently than expected and 
are associated with an increased adverse event [13].
Furthermore, a potential difficulty in 
differentiating between PAE and acute peripheral 
arterial thrombosis in patients with pre-existing PAD 
could be a major cause of delayed treatment in acute 
emboligenic occlusion [14].
A study showed that the greatest source of 
delay is time from symptom onset to presentation in the 
emergency department (ED); an average of 11.35 h. 
The second largest source of delay was time from 
recognition of PAE to imaging, with an average delay 
of 4.75 h. The average ED evaluation time was 40 min, 
and the average total time to intervention was 10.2 h. 
While time to symptom presentation may represent a 
failure of public health, time to imaging was identified 
as an area of unacceptable delay by the authors [15].
A swede study examined the effect of pre-
hospital care on the time to treatment. Persons who 
were transported through emergency medical services 
(EMSs) arrived to the hospital at a median time of 5 
h after symptom onset, were seen by a physician at 
a median time of 51 min, and had revascularization at 
a median time of 23 h. Those not transported by EMS 
arrived to the hospital at a median time of 48 h after 
symptom onset, were seen by a physician at a median 
time of 80 min, and had revascularization at a median 
time of 93 h [16]. In a condition where minutes matter, 
expedient action is critical. Time to recognition, imaging, 
consultation, and intervention all are potential sources 
of delay [17].
It is uncertain in our study group if the 
opportunities for timely diagnosis have “just been 
missed” or it concerns a group of patients being 
improperly treated due to health-care system problems, 
poor preparation of medical specialists regarding 
vascular pathologies or due to a lack of a unified 
standard for the treatment of vascular diseases.
Conclusion
The consequences of acute limb embolism such 
as prolonged hospitalization, major limb amputation, 
and/or death have a profound socioeconomic impact.
Unrecognition of this vascular pathology and 
differential diagnosis difficulties is possibly leading 
factors for delayed or missed treatment.
Further research is required to analyze and 
understand the cause for these opportunities being 
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delayed or missed and to develop strategies that would 
prevent future complications and amputations.
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